- Home
- MNKD vs PDM Comparison
MNKD vs PDM Comparison
Compare MNKD & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | PDM |
|---|---|---|
| Founded | 1991 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2004 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MNKD | PDM |
|---|---|---|
| Price | $3.76 | $9.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $8.69 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 3.1M | 966.9K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $348,966,000.00 | ★ $564,994,000.00 |
| Revenue This Year | $35.81 | $4.21 |
| Revenue Next Year | $11.89 | $1.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.23 | $6.32 |
| 52 Week High | $6.51 | $10.13 |
Technical Indicators
Market Signals| Indicator | MNKD | PDM |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 45.05 |
| Support Level | $3.30 | $9.41 |
| Resistance Level | $4.23 | $9.97 |
| Average True Range (ATR) | 0.17 | 0.22 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 0.00 | 10.74 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.